The PCCTC’s IRONMAN Registry Receives PCF Challenge Award

Principal Investigators Lorelei Mucci, ScD, MPH (Harvard T.H. Chan School of Public Health), and Daniel George, MD (Duke University) were named recipients of a 2022 Prostate Cancer Foundation (PCF) Challenge Award for their proposal, IRONMAN: Enhancing Survivorship in Patients with Advanced Prostate Cancer. The IRONMAN Registry (ClinicalTrials.gov Identifier: NCT03151629) is managed by the Prostate Cancer


More than 40,000 oncology professionals from around the world will convene at the annual American Society of Clinical Oncology (ASCO) meeting this year in Chicago, IL and online. The ASCO annual meeting is a unique and unparalleled opportunity to connect with one of the largest, most diverse audiences in global cancer care, and the Prostate

Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling

  Collaboration will comprehensively profile DNA, RNA and proteins on patient samples from the Phase 2 Maverick trial to understand mechanisms of disease response and resistance IRVING, Texas and SAN DIEGO, California, June 2, 2022 – Caris Life Sciences® (Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize

The transformative development and progress of the The PCCTC via UroToday

Charles Ryan is joined by the leadership of the Prostate Cancer Clinical Trials Consortium, a group that has developed innumerable trials and therapies for advanced prostate cancer. The Prostate Cancer Clinical Trials Consortium (PCCTC) was initiated in 2005 by the Prostate Cancer Foundation (PCF) and the U.S. Department of Defense (DOD) Prostate Cancer Research Program

Hello world!

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!